STOCK ALARM
PRO
SA
PRO
News
Screener
Rankings
Themes
Alerts
More
⌘
K
⌘
J
Pro
Sign In
Free Account
Themes
Lyra Therapeutics, Inc.
LYRA
NASDAQ
Loading
Overview
Intelligence
Charts
News
Fundamentals
Financials
Analysis
More
Key Metrics
Explore More
S&P 500 Screener
Filter and sort all 500 stocks
Market Movers
Today's biggest gainers and losers
Market Heatmap
Visual sector performance
Loading chart...
As of
2024
• vs 2023
Annual
Quarterly
Core Metrics
Market Cap
$671.98M
-94.8%
P/E Ratio
-7.19
+96.5%
P/S Ratio
438.05
-94.8%
ROE
-805.89%
-1049.7%
ROIC
-166.59%
-218.8%
FCF Yield
-10.77%
-2080.6%
Debt/Equity
2.97
+886.4%
Current Ratio
3.41
-36.3%
Interest Coverage
0.00x
Per Share
Revenue/Share
$0.02
-24.8%
Net Income/Share
$-1.43
-13.9%
Operating CF/Share
$-1.08
+15.5%
Free CF/Share
$-1.11
+14.1%
Cash/Share
$0.62
-69.8%
Book Value/Share
$0.18
-90.1%
Tangible Book/Share
$0.18
-90.1%
Equity/Share
$0.18
-90.1%
Interest Debt/Share
$0.53
-2.3%
Valuation
Market Cap
$671.98M
-94.8%
Enterprise Value
$665.78M
-94.9%
P/E Ratio
-7.19
+96.5%
P/S Ratio
438.05
-94.8%
P/OCF Ratio
-9.60
+95.3%
P/FCF Ratio
-9.29
+95.4%
P/B Ratio
57.96
-60.2%
P/TB Ratio
57.96
-60.2%
EV/Sales
434.01
-94.8%
EV/EBITDA
-11.05
+94.5%
Profitability
Earnings Yield
-13.90%
-2791.3%
FCF Yield
-10.77%
-2080.6%
ROE
-805.89%
-1049.7%
ROIC
-166.59%
-218.8%
Return on Tangible Assets
-140.83%
-220.4%
Capital Allocation
CapEx/OCF
-3.34%
-101.9%
CapEx/Revenue
152.41%
+126.8%
CapEx/Depreciation
4.96
+31.8%
SBC/Revenue
437.81%
+15.9%
Balance Sheet
Debt/Equity
2.97
+886.4%
Debt/Assets
0.52
+174.9%
Net Debt/EBITDA
0.10
+248.2%
Current Ratio
3.41
-36.3%
Interest Coverage
0.00x
Income Quality
0.75
-25.8%
Efficiency
Days Sales Outstanding
0 days
Days Payables Outstanding
0 days
Days Inventory
0 days
Receivables Turnover
0.00x
Payables Turnover
0.00x
Inventory Turnover
0.00x
Special Valuations
Graham Number
--
Graham Net-Net
$-0.22
-121.8%